Ochre Bio

Founders

Jack O'Meara (CEO), Quin Wills

Website

ochre-bio.com

Twitter

@OchreBio

Location

London

RELATIONSHIP

Expa Ventures

The liver medicines company.

Ochre Bio develops RNA therapies for chronic liver disease (a top ten cause of death) using a combination of genomics, machine learning and experimental biology on live human organs.

News

Mar 15, 2023

Forbes

Ochre Bio’s O’Meara named to 30 under 30 Europe Ochre Bio’s O’Meara named to 30 under 30 Europe

Oct 10, 2022

Yahoo!

Ochre Bio raises $30M Series A financing for the development of RNA therapies for chronic liver diseases Ochre Bio raises $30M Series A financing for the development of RNA therapies for chronic liver diseases